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Summary
Eubacterium rectale is a prominent human gut sym-
biont yet little is known about the molecular strate-
gies this bacterium has developed to acquire
nutrients within the competitive gut ecosystem.
Starch is one of the most abundant glycans in the
human diet, and E. rectale increases in vivo when
the host consumes a diet rich in resistant starch,
although it is not a primary degrader of this glycan.
Here we present the results of a quantitative proteom-
ics study in which we identify two glycoside hydro-
lase 13 family enzymes, and three ABC transporter
solute-binding proteins that are abundant during
growth on starch and, we hypothesize, work together
at the cell surface to degrade starch and capture
the released maltooligosaccharides. EUR_21100 is a
multidomain cell wall anchored amylase that prefer-
entially targets starch polysaccharides, liberating
maltotetraose, whereas the membrane-associated
maltogenic amylase EUR_01860 breaks down maltoo-
ligosaccharides longer than maltotriose. The three
solute-binding proteins display a range of glycan-
binding specificities that ensure the capture of
glucose through maltoheptaose and some α1,6-
branched glycans. Taken together, we describe a
pathway for starch utilization by E. rectale DSM 17629
that may be conserved among other starch-degrading
Clostridium cluster XIVa organisms in the human gut.
Introduction
The human gut microbiota is established soon after birth
and plays several important roles in human health by
guiding the development of the immune (Mazmanian
et al., 2005) and gastrointestinal systems (Stappenbeck
et al., 2002), preventing enteric pathogen invasion
(Mazmanian et al., 2008) and degrading and fermenting
dietary glycans into host-absorbable short-chain fatty
acids (SCFAs). The composition of the gut community is
largely bacterial, and despite the presence of hundreds of
species, it is dominated by two bacterial phyla: the Bac-
teroidetes and Firmicutes (Eckburg et al., 2005; Ley et al.,
2006a,b). Key to the survival of these organisms in the
mammalian intestinal tract is their ability to forage carbo-
hydrate nutrition of dietary or host origin, making diet a
controllable variable that shapes the human gut microbial
community composition and metabolic output (Koropatkin
et al., 2012).
Eubacterium rectale is a member of the Clostridium
cluster XIVa group of the Firmicutes (Duncan and Flint,
2008) and is a common member of the human gut micro-
biota (Hold et al., 2003; Qin et al., 2010; Arumugam et al.,
2011; Kraal et al., 2014). E. rectale as well as other
members of this cluster produce the SCFA butyrate as a
primary fermentation end-product (Pryde et al., 2002).
Butyrate is not only the primary fuel source of colonocytes,
but also a potent anti-inflammatory (Segain et al., 2000)
and anti-tumorigenic molecule, thus making butyrate-
producing organisms in the intestinal tract of special inter-
est in the prevention and treatment of inflammatory bowel
diseases as well as colorectal cancers (Hamer et al., 2008;
Van Immerseel et al., 2010). Furthermore, the abundance
of butyrate-producing organisms is observed to be mark-
edly decreased in individuals suffering from several intes-
tinal and systemic diseases, such as ulcerative colitis
(Morgan et al., 2012; Nemoto et al., 2012; Machiels et al.,
2014), Crohn’s disease (Frank et al., 2007; 2011; Kang
et al., 2010; Willing et al., 2010; Gevers et al., 2014), colo-
rectal cancer (Wu et al., 2013) and diabetes (Larsen et al.,
2010; Qin et al., 2012; Karlsson et al., 2013; Peng et al.,
2014), suggesting the importance of these organisms in
maintaining optimal health.
Compared with members of the Bacteroidetes phylum,
E. rectale and other members of the Clostridium cluster
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XIVa, possess a smaller repertoire of glycoside hydro-
lases, suggesting a limited ability to degrade a variety of
complex polysaccharides (El Kaoutari et al., 2013). The
abundance of Clostridium cluster XIVa organisms tracks
closely with the prevalence of plant polysaccharides in the
diet in both human and animal studies, with the proportion
of these organisms significantly decreased on low-
polysaccharide diets (Duncan et al., 2007; Mahowald
et al., 2009; Walker et al., 2011). More specifically, diets
supplemented with resistant starch (RS), a general term
describing dietary starch that is relatively inaccessible to
human (gluco)amylases due to its physical structure,
cause an increase in the abundance of these organisms
(Martinez et al., 2010; Conlon et al., 2012). Dietary
resistant starch has been demonstrated to increase the
relative butyrate production by the gut microbiota in both
in vivo (van Munster et al., 1994; Abell et al., 2008;
Conlon et al., 2012) and in vitro fermentation studies
(Wang et al., 2004). An increase in butyrate may explain
why dietary RS has been shown to be protective against
DNA damage and the subsequent development of colo-
rectal cancer in a mouse model of azoxymethane-induced
colorectal cancer (Clarke et al., 2008).
One explanation for the increase in butyrate output and
Clostridium cluster XIVa abundance from the fermentation
of RS is that these organisms are primary degraders of
the material and possess the enzymatic machinery for
degradation. This hypothesis was supported by earlier
work demonstrating that that these species adhere to RS
particles and are often associated with the insoluble
dietary material found in feces (Leitch et al., 2007; Walker
et al., 2008). However, more recent work has demon-
strated that E. rectale in monoculture cannot utilize RS,
but rather another organism such as Ruminococcus
bromii is required to begin the initial degradation of the RS
granules, liberating material that E. rectale can utilize (Ze
et al., 2012). When R. bromii and E. rectale are grown in
coculture with RS as the sole carbon source, E. rectale
becomes threefold more abundant than R. bromii after
48 h of growth, suggesting that E. rectale is adept at scav-
enging the starch, maltooligosaccharides or glucose lib-
erated by the amylotytic activity of R. bromii. However, the
molecular details of nutrient uptake and scavenging by
E. rectale are poorly understood. Understanding how
these organisms scavenge starch and contribute to its
degradation and consumption by the gut microbiome can
lead to advances in the development of prebiotics to spe-
cifically increase the abundance of these dominant
butyrate producers.
In order to identify the proteins involved in starch utiliza-
tion by E. rectale DSM 17629 (i.e. E. rectale A1–86), we
performed a quantitative proteomics analysis on combined
cell wall and membrane fractions and biochemically char-
acterized several adenosine triphosphate (ATP)-binding
cassette (ABC) solute-binding proteins and two glycoside
hydrolases abundant during cell growth on starch. Using
these data, we propose a model for starch utilization by
E. rectale that involves the coordinated action of at least
one extracellular amylase that hydrolyzes starch into
maltooligosaccharides that are recognized by at least two
of the ABC solute-binding proteins.
Results
Growth on starch and maltooligosaccharides
E. rectale was cultured in 96 well plates in an anaerobic
chamber to determine its ability to utilize various starches
and maltooligosaccharides (Fig. 1). Corroborating previ-
ous reports, E. rectale grows rapidly on branched, soluble
starch polysaccharides including potato amylopectin,
maize amylopectin (APM), and glycogen, but much less
efficiently on autoclaved Hylon VII (H7), a commercial
resistant corn starch comprised of 70% amylose (Duncan
and Flint, 2008; Ze et al., 2012). It cannot grow at all on
pullulan, a fungal cell wall component comprised of α1,6-
Fig. 1. Growth of E. rectale DSM 17629 on starch and
maltooligosaccharides. Bacteria were grown in 96 well plates in a
37°C anaerobic chamber with the OD600 automatically recorded
every 20 min. YCFA media was supplemented with 2 mg mL−1 of
the listed carbohydrates as the sole carbon source.
A. Growth on starches (APM, maize amylopectin; APP, potato
amylopectin; H7, Hylon VII); water is displayed as a negative
control. Note that autoclaved H7 is a turbid suspension that was
not blanked in this set of experiments.
B. Growth on maltooligosaccharides (G3, maltotriose; G7,
maltoheptaose; aCD, α-cyclodextrin; bCD, β-cyclodextrin; GM,
glucosyl-α1,6-maltotriose; GMM,
glucosyl-α1,6-maltotriose-α1,6-maltotriose).
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linked maltotriose but can grow on pullulan oligosaccha-
rides including glucosyl-α1,6-maltotriose-α1,6-maltotriose
(GMM) and glucosyl-α1,6-maltotriose (GM). Although it
was previously reported that E. rectale cannot grow on
isomaltose, we demonstrate it can grow on the trisac-
charide panose (glucose-α1,6-glucose-α1,4-glucose),
although at a reduced growth rate. E. rectale also grows
well on maltose, maltotriose (G3) and maltoheptaose (G7)
but not on α-cyclodextrin (aCD) or β-cyclodextrin (bCD).
Quantitative proteomic analysis of cell
wall/membrane samples
To identify enzymes and transporters key for the growth
of E. rectale on starch, we performed a quantitative prot-
eomic analysis of combined cell membrane/cell wall
samples. The bacteria were grown in Hungate tubes on
YCFA media containing either 2 mg mL−1 of glucose
(GLU), autoclaved APM or autoclaved H7 as the sole
carbon source.Amylopectin is a soluble component of corn
starch by virtue of its regular α1,6-linked branch points,
whereas H7 is an insoluble corn starch that is resistant to
degradation due to its high amylose content; these
starches differ in their physiochemical properties and are
representative of the prominent forms of starch in the
human diet. Biological triplicates of each culture grown in
APM, H7 or GLU were harvested at mid-log phase
(OD600 = 0.6) for combined cell membrane/cell wall extrac-
tion. Among all nine samples, a total of 828 proteins were
detected (Supporting Information Table S1). Seven out of
nine samples had a false discovery rate (FDR) of 0%, and
one H7 and oneAPM sample each had an FDR of 0.2%. Of
the 828 proteins, 421 are predicted by PSORTb 3.0 to be
localized to the cytoplasm, 6 to the cell wall, 258 to the cell
membrane, 12 to extracellular environment and 133 were
annotated as having an unknown location. That just over
half of the proteins identified have a predicted cytoplasmic
localization was not surprising, as we intentionally used
wash conditions to preserve cell membrane and cell wall
associated proteins. Of the cytoplasmic proteins, 132 had
predicted roles in housekeeping functions such as tran-
scription, translation and replication. In addition, proteins of
central metabolic importance were observed; such pro-
teins have been observed to associate with the cell wall
and membrane in diverse species such as Clostridium
thermocellum (Yu et al., 2012) and Streptococcus oralis
(Maeda et al., 2013), and thus these proteins in E. rectale
may normally associate with the cell membrane.
Protein abundance was calculated using the normal-
ized spectral abundance factor (NSAF, see Experimental
procedures), which reports the relative abundance of the
identified protein within a sample, normalized for the
molecular weight of the protein. Spectral counting includ-
ing NSAF is a well-documented quantity for measuring
the relative abundance of proteins within and between
samples and can accurately determine protein abun-
dance changes of 2.5-fold (Colinge et al., 2005; Old et al.,
2005). We therefore set a stringent cutoff of three-fold for
proteins reported as more abundant on either starch- or
glucose-grown cells.
ABC transporters and glycoside hydrolases upregulated
during growth on starch
A total of 24 proteins were identified that increased three-
fold or more in abundance during growth on either H7
or APM (or both) compared with growth on glucose
(Supporting Information Table S2), and eight of these
have predicted functions in carbohydrate metabolism and
transport (COG G; Table 1). Six of these proteins are
predicted to be components of ABC transporters, and two
are annotated as members of glycoside hydrolase family
13 (GH13), comprising enzymes that target glycosidic
linkages in starch. ABC transporters involved in bacterial
nutrient import are typically comprised of three functional
proteins or domains: a solute-binding protein that binds
the molecule to be imported, one or more transmembrane
permeases to which the solute-binding protein docks and
releases the bound molecule, and a cytosolic ATPase that
hydrolyzes ATP to induce a conformational change in the
permease allowing solute passage into the cytoplasm
(Rees et al., 2009).
EUR_01830 is a predicted carbohydrate ABC trans-
porter solute-binding protein, and the most abundant
protein differentially expressed during growth on starch,
displaying an NSAF of 2.36 ± 0.11% in H7 and
1.69 ± 0.15% in APM and fold changes of 6.5 and 4.7 on
H7 and APM respectively, compared with glucose. A
BLAST search of this protein against the protein data bank
(PDB) reveals ∼ 25% sequence identity to several maltose-
and maltooligosaccharide-binding proteins including those
from Thermoactinomyces vulgaris (pdb 2ZYK, Matsumoto
et al., 2009) and S. pneumoniae (pdb 2XD2, Abbott et al.,
2010). Within the E. rectale DSM 17629 genome,
EUR_01830 shares 50% amino acid sequence similarity
with EUR_14180, which is annotated as a MalE (maltose-
binding protein) homologue, although it is found at low
levels in our samples and elevated during growth on
glucose (Supporting Information Table S1). EUR_01830 is
encoded in a putative operon with EUR_01840 and
EUR_01850, both predicted ABC membrane permeases,
as well as EUR_01860, a GH13 glycosidase, all of which
were differentially expressed in starch-grown cells (Fig. 2).
A BLAST search of EUR_01860 against amino acid
sequences in the PDB reveals 35% identity (47% similar-
ity) to a characterized α-amylase from Halothermothrix
orenii (pdb 1WZA, Sivakumar et al., 2006), as well as 33%
identity (46% similarity) to the catalytic domain of the
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surface amylase SusG from Bacteroides thetaiotaomicron
(Koropatkin and Smith, 2010). EUR_01860 is predicted to
have an N-terminal transmembrane helix (TMHMM server
v 2.0, http://www.cbs.dtu.dk/services/TMHMM/), suggest-
ing it is anchored to the cell membrane (Fig. 3). Although
the genomic organization indicates that EUR_01830
through EUR_01860 denote a single operon, EUR_01860
is upregulated several fold more than the ABC transporter
proteins, with fold changes of 18.3 and 13.3 for growth in
H7 and APM, respectively, compared with GLU.
EUR_31480 is the second most abundant protein
expressed during growth on starch, although the relative
fold change compared with growth on glucose (3.1-fold
and 2.7-fold for H7 and APM growth respectively) is lower
than proteins of the EUR_01830–01860 operon. Of
proteins in the PDB, EUR_31480 shares significant
sequence homology (> 20% identity, > 35% similarity)
over most of its length with the ABC xylo-oligosaccharide
binding protein from Caldanaerobius polysaccharolyticus
(4G68, Han et al., 2012) as well as the ABC acarbose-
binding protein GacH from Streptomyces glaucescens
(3JYR, Vahedi-Faridi et al., 2010). The gene encoding
EUR_31480 is part of a putative operon containing a
predicted ABC permease (EUR_31500) and ATPase
(EUR_31490), both of which were identified in the starch-
grown cell samples at lower relative abundance. Just
downstream of this gene cluster resides a predicted LacI-
family transcriptional regulator (EUR_31510), a predicted
permease (EUR_31520), a predicted multi-antimicrobial
efflux family pump (EUR_31530) and a gene of unknown
Fig. 2. Genomic neighborhood of the genes
encoding the differentially expressed proteins
detected during growth on starch. Each gene
is drawn to scale as a rectangle with its
orientation indicated by the closed triangle.
Genes have been color coded according to
annotated function (IMG: img.jgi.doe.gov), or
labeled: efflux protein MATE, multi-
antimicrobial efflux protein pump; DMT
permease, drug metabolite transporter/
permease; RNRII, ribonucleotide reductase
class II activase subunit; TrxB, thioredoxin;
ABC ATPase, ABC transporter ATP-binding
protein.
Fig. 3. Domain organization of EUR_21100 and EUR_01860. EUR_21100 is multimodular with several N-terminal domains that resemble
CBMs (via BLAST search against isolated CBM sequences). Between the putative CBMs and the catalytic module (also GH13), there is a
region of unknown function that does not resemble any previously characterized domains. At the C-terminal end, there is a putative cell wall
anchoring motif that likely attaches this protein to the peptidoglycan layer. In contrast, EUR_01860 consists of a single module, a GH13
catalytic domain, with an N-terminal transmembrane helix. Arrows indicate regions of the proteins that were cloned for biochemical
characterization.
Starch utilization by Eubacterium rectale 213
© 2014 John Wiley & Sons Ltd, Molecular Microbiology, 95, 209–230
function (EUR_31540). Although both EUR_31520 and
EUR_31540 are predicted to localize to the cell mem-
brane, they were barely above the threshold for detection
(two unique peptides) in any of the samples.
Although much less abundant than the aforementioned
proteins, the solute-binding protein EUR_21010 is 5.7-fold
more abundant in H7 grown cells, though only two-fold
more abundant in APM cells compared with GLU grown
cells. Genomic context suggests it is also expressed within
a genetic cluster encoding two predicted ABC membrane
permeases (EUR_21020 and EUR_21030). Downstream
of the ABC permease genes are three additional
genes, which may or may not be co-transcribed with
EUR_21010 : EUR_21040, a predicted drug metabolite
transporter; EUR_21050, a predicted ribonucleotide-
triphosphate reductase class II activase subunit; and
EUR_21060, a hypothetical protein of unknown function.
Upstream of EUR_21010, there is a predicted LacI family
transcriptional regulator, EUR_21000, and a predicted cel-
lobiose phosphorylase, EUR_20990. Surprisingly, despite
the wealth of protein structures that have been solved for
ABC solute-binding proteins, a BLAST search of the
EUR_21010 amino acid sequence of to the PDB did not
convey homology to any other structurally characterized
solute-binding protein.
EUR_21100, a predicted GH13 family enzyme, is
detected only in starch-grown cells and is comprised of
1365 amino acids, with a putative cell wall sorting signal
(APKSGD, residues 1329 to 1334), that may be recog-
nized via a SrtA or SrtB pathway (Comfort and Clubb,
2004). Based upon comparative sequence analysis with
known starch-binding carbohydrate-binding module
(CBM) families, we predict that this amylase has several
tandem CBMs most closely resembling the starch-specific
families CBM26 (BLAST E-value 2e−5) and CBM41
(BLAST E-value 1e−5–5e−7) at its N-terminus, with the
catalytic domain at the C-terminus (Fig. 3). While this
degree of similarity is not sufficient to assign the
N-terminal domains of EUR_21100 to these particular
CBM families, it does suggest they perform a similar func-
tion, i.e. carbohydrate binding. The remaining genes adja-
cent to EUR_21100 encode a putative transcriptional
regulator, a protein of unknown function and a thioredoxin.
Of these genes, the protein product for the transcriptional
regulator EUR_21110 was observed at the limit of detec-
tion (two spectra) in two of the glucose samples and not at
all in any other samples.
While secondary to the goal of this study, we performed
an inverse analysis of the proteins three-fold or more
abundant during growth on GLU as opposed to either
APM or H7 (Table 1, Supporting Information Table S3).
We did not detect any putative glucose transporters in this
analysis, but rather noted several cytoplasmic enzymes
involved in the regulation of glycogen synthesis. All of
these proteins are of relatively low abundance compared
with the aforementioned proteins that are upregulated
during cell growth on starch. EUR_00180 is a predicted
phosphoenolpyruvate (PEP) phosphotransferase that
cleaves phosphate from PEP and is ultimately used
to phosphorylate monosaccharides like glucose that
are imported into the cytoplasm. The other proteins,
EUR_20850 (glycogen phosphorylase), EUR_28650 (gly-
cogen branching enzyme, GlgB) and EUR_16230 (glyco-
gen synthase, GlgA), are involved in the regulation of
cellular glycogen levels. Glycogen synthase EUR_16230
abundance was not significantly different between APM
and glucose-grown cells, and E. rectale’s growth rate on
these carbon sources is similar, while the cells grow more
slowly on H7 which contains a higher percentage of RS. It
is possible that during exponential growth on more readily
accessible carbon sources like glucose, E. rectale, like
some other bacteria, begins to synthesize the carbon
storage molecule glycogen (Gibbons and Kapsimalis,
1963; Wilson et al., 2010) This may contribute to E. rec-
tale’s prominence and survival in the gut, despite its rela-
tively limited repertoire of carbohydrates that it can utilize
compared with other gut bacteria. It should be noted that
another proteomic investigation of the related bacterium
Roseburia inulinovorans also revealed an upregulation of
glycogen phosphorylase during growth on starch vs
growth on the plant fructan inulin (Scott et al., 2011).
Because some enzymes produce glucose directly
during starch digestion, we looked for putative glucose-
specific transporters in our data sets that fell below the
stringent three-fold cutoff (Table 2). Several proteins
encoding phosphotransferase system (PTS) components
(EUR_10290, and EUR_28570) are found in samples with
an NSAF of 0.1% or greater and slightly higher in abun-
dance on glucose compared with starch-grown cells.
These proteins are annotated as components of glucose
and fructose-targeting PTS systems respectively. The
predicted ABC solute-binding proteins EUR_31580 and
EUR_14180 are nearly two-fold more abundant in GLU
compared with APM grown cells. As mentioned earlier,
EUR_14180 is annotated as MalE (maltose-binding
protein), but the target ligand for EUR_31580 cannot be
predicted. EUR_08690 and EUR_08700 comprise parts
of a PTS that are slightly more abundant in starch-grown
cells over glucose-grown cells. EUR_08700 is annotated
as a putative PTS IIC permease that may recognize the
sugars maltose or glucose for transport across the cell
membrane. Of the ABC transport solute-binding proteins,
EUR_01240, a putative glucose-galactose binding
protein, displays a relatively high abundance in all three
growth conditions, though somewhat elevated in starch-
grown cells, and so we included this protein in our list of
potential maltose/malto-oligosaccharide targeting trans-
porters. A BLAST search of the EUR_01240 amino acid
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sequence to the PDB revealed it is 30% identical (44%
similar) to the ABC glucose-binding protein from Escheri-
chia coli (pdb 2HPH) and 31% identical (44% similar) to
the ABC glucose/galactose-binding protein from Salmo-
nella typhimurium (pdb 1GCA) (Mowbray et al., 1990).
Curiously, EUR_01240 has an extra ∼ 100 amino acids at
its C-terminus compared with these well-characterized
binding proteins. Like the aforementioned solute-bind-
ing proteins, Eur_01240 is part of a putative operon
encoding both an ABC ATPase and membrane permease
(Fig. 2).
GH13 enzymes EUR_01860 and EUR_21100 target
different starch molecules
In order to clarify the roles of the two enzymes that are
most upregulated in the presence of starch, they were
expressed, purified and biochemically characterized
(Table 3). EUR_01860 displays its maximal activity against
β-cyclodextrin (100%) and maltotriose (67%), with only
weak activity against the soluble starch polymer amylopec-
tin (23%) and trace activity on amylose (5%) and insoluble
corn starch (1%). This is perhaps unsurprising as this
enzyme lacks CBMs that facilitate activity against polysac-
charides, though it is currently unknown if this enzyme
possesses a surface binding site, which are often found
to either replace or work in conjunction with CBMs in
GH13 enzymes (Nielsen et al., 2009; Koropatkin and
Smith, 2010; Cockburn and Svensson, 2013). Although
EUR_01860 has detectable activity on maltotriose as
determined by a glucose oxidase (GO) assay (Table 3), it
seems to prefer oligosaccharides with a degree of polym-
erization of four or longer. Thin layer chromatography
(TLC) on the digestion products of EUR_01860 with mal-
totetraose through maltoheptaose (Fig. 4A) demonstrates
that the enzyme has approximately equal activity on these
substrates, whereas products from a similar assay with
maltotriose can barely be detected (data not shown).
EUR_01860 has weak but detectable activity against α1,6
linkages, demonstrated by the low-level production of mal-
totriose from GMM (Fig. 4B) and is able to hydrolyze
cyclodextrins (Fig. 4B). The result of prolonged incubation
of EUR_01860 with maltotetraose, maltohexaose or glyco-
gen is maltose is along with a small amount of maltotriose
(Supporting Information Fig. S1). This set of characteris-
tics most closely resembles the maltogenic α-amylases/
cyclodextrinases, although EUR_01860 lacks the N-
terminal domain that is the main identifying feature of these
enzymes (Lee et al., 2002). Furthermore, BLAST searches
against the GH13 enzymes that have been assigned to
subfamilies revealed that EUR_01860 is most closely
related to the subfamily 31 enzymes (α1,6 glucosidases)
rather than the maltogenic α-amylases/cyclodextrinases
found in subfamilies 2 and 20 (Stam et al., 2006).
In contrast to EUR_01860, EUR_21100 is most active
against polymeric substrates, displaying maximal activity
against the soluble starch component amylopectin with
high activity on glycogen (90%) and amylose (56%) as
determined by reducing sugar assays. However, this
enzyme can also degrade intact starch granules as dem-
onstrated by its activity on granular corn starch (7%) and
H7 (8%). TLC analysis reveals that the main product of
starch degradation by EUR_21100 is maltotetraose, with
significant amounts of maltopentaose (Fig. 4C). Not sur-
prisingly, EUR_21100 has no detectable activity against
maltose, maltotriose (Table 3) or maltotetraose but dis-
plays weak activity on maltopentaose and can hydrolyze
longer maltooligosaccharides such as maltohexaose and
maltoheptaose (Fig. 4D). This enzyme is thus classified as
a maltotetraose-producing α-amylase (Yoshioka et al.,
1997) even though BLAST searches suggest it is more
closely related to type I pullulanases (α1,6 hydrolyzing
Table 3. Specific activities for EUR_01860 and EUR_21100.
Substrate
EUR_01860 EUR_21100
SA ± SD
(μmol min−1 mg−1)
% Maximal
activity
SA ± SD
(μmol min−1 mg−1)
% Maximal
activity
Amylopectin (0.3%) 1.43 ± 0.15 23 62.57 ± 2.46 100
Glycogen (0.3%) 2.60 ± 0.21 42 56.37 ± 2.54 90
Amylose (0.3%) 0.29 ± 0.03 5 34.76 ± 3.82 56
Pullulan (0.3%) 0.58 ± 0.49 9 1.09 ± 0.26 2
Dextran (0.3%) 0.12 ± 0.06 2 0.00 ± 0.14 0
β-cyclodextrin (0.3%) 6.14 ± 0.51 100 7.19 ± 0.76 11
α-cyclodextrin (0.3%) 0.33 5 1.86 ± 0.41 3
Corn starch (0.3%) 0.09 ± 0.07 1 4.24 ± 0.23 7
Hylon VII (H7, 0.3%) NDa NDa 5.08 ± 1.60 8
Maltose (5 mM) 0.12 ± 0.33 2 0.09 0
Maltotriose (5 mM) 4.11 ± 0.46 67 0.31 0
Average of three assays per substrate reported.
a. ND – not determined.
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enzymes) in subfamilies 12 and 14 of GH13 (Stam et al.,
2006).
While from Table 3 it appears that EUR_21100 is much
more active against the soluble components of starch
than against starch granules, it should be kept in mind that
these values were all acquired at 0.3% w/v of substrate
and that for a given weight starch granules will have a
far lower accessible area than soluble amylopectin.
Using 10% granular starch the specific activity rises
to 81.66 μmol min−1 mg−1, significantly higher than the
62.57 μmol min−1 mg−1 seen for amylopectin, which does
not increase when the substrate concentration is raised to
1%. Interestingly, EUR_21100 had nearly identical activity
toward H7 as toward normal corn starch. However, these
are only initial activities and likely reflect that H7 is com-
posed of approximately 50% RS (Vonk et al., 2000; Jiang
and Liu, 2002), so it is unsurprising that it resembles
regular corn starch in the initial stages of degradation.
EUR_01830 targets maltooligosaccharides of three
glucose units and longer
To determine how the abundant carbohydrate-binding
protein EUR_01830 assists in nutrient capture during
growth on starch, we expressed and purified this protein
(residues 24–422, removing the signal peptide) for bio-
Fig. 4. Thin layer chromatography of enzyme hydrolysis products. Each reaction was analyzed at four time points: 0, 10, 20, 30 min. Lanes
denoted C are TLC controls consisting of 2 nmol each of glucose, maltose and maltotriose.
A. EUR_01860 hydrolysis of maltooligosaccharides.
B. EUR_01860 hydrolysis of GMM and BCD. Lane Pan is a 5 nmol panose standard, and lane GM is a 5 nmol glucose-α1,6-maltotriose (GM)
standard.
C. EUR_21100 hydrolysis of amylopectin. Lane G4 is a 5 nmol maltotetraose standard.
D. EUR_21100 hydrolysis of maltooligosaccharides. Abbreviations are as follows: β-cyclodextrin (BCD), glucose (Glc), maltose (G2),
maltotriose (G3), maltotetraose (G4), maltopentaose (G5), maltohexaose (G6), maltoheptaose (G7), glucose-α(1,6)-maltotriose (GM),
glucose-α(1,6)-maltotriose-α(1,6)-maltotriose (GMM), panose (Pan).
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chemical characterization. Via isothermal titration calorim-
etry (ITC), EUR_01830 binds maltooligosaccharides of
three to seven glucose units with relatively equal affinity (Kd
range 288–550 nM, Table 4). EUR_01830 displays no
detectable affinity for maltose, suggesting that at least
three subsites within the binding pocket must be occupied
for efficient binding. A 100-fold reduction in affinity was
observed for binding to α-cyclodextrin (Kd = 39 900 ±
2430 nM), suggesting that this is not a biologically relevant
substrate; likewise, E. rectale cannot grow on α- or
β-cyclodextrin. Although E. rectale cannot grow on pullu-
lan, it can grow on oligosaccharides generated from the
breakdown of pullulan. EUR_01830 can bind the short
pullulan oligosaccharide GM (Kd = 9080 ± 618 nM), most
likely because the maltotriose moiety engages the pre-
dicted three essential subsites required for binding,
although there is a > 10-fold reduction in affinity compared
with α1,4-linked maltooligosaccharides. We obtained an
isotherm with GMM, but these data could not be fit well
enough to obtain an accurate Kd; thus, this substrate is
unlikely to be biologically relevant. Like some acarbose-
recycling solute-binding proteins, EUR_01830 can bind
acarbose (Kd 302 ± 21.8 nM) with similar affinity as other
maltooligosacharides (Vahedi-Faridi et al., 2010).
To examine the molecular basis of maltooligosaccha-
ride discrimination, we determined the crystal structures
of EUR_01830 complexed with either maltotriose
(1.54 Å, Rwork = 13.7%, Rfree = 16.1%) or acarbose (1.6 Å,
Rwork = 14.4%, Rfree = 17.7%; Table 5, Fig. 5A and B). The
structure of EUR_01830 displays a type II two-domain
solute-binding fold with a ligand-binding site located at the
interface between the N- and C-terminal domains, con-
nected by three β-strands, residues 152–157, 300–309
and 371–374 (Fig. 5B). The closest structural homolog of
EUR_01830 via a Dali search (http://ekhidna.biocenter
.helsinki.fi/dali_server; Holm and Sander, 1995) is the
maltose–maltodextrin binding protein from Alicyclobacil-
lus acidocaldarius (pdb 1URG, Z = 39.2, rmsd = 2.0 Å for
350 residues, Schafer et al., 2004), though numerous
maltose- and maltodextrin-binding proteins display strik-
ing similarity (Z ≥ 33, rmsd ≤ 2.5 Å), including MalX from
S. pneumoniae (Abbott et al., 2010) and MalE from E. coli
(Oldham et al., 2013), both of which can accommodate
sugars as long as maltoheptaose.
The structure of the EUR_01830 maltotriose-bound
and acarbose-bound structures are nearly identical
(0.1 Å rmsd for 383 amino acids; Fig. 5B). Like other
maltodextrin-binding proteins, the binding pocket consists
of three aromatic residues, here W267, W193 and W383,
that stack with Glc1–3 (Fig. 5C). An additional hydrogen-
bonding network between the residues that line the inner-
most hinge region of the binding cleft and the O2 and O3
hydroxyls of these Glc residues further facilitate binding.
The reducing end sugar (Glc1) is recognized by the protein Ta
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via both water-mediated and direct hydrogen bonding
(Fig. 5D). The O2 and O3 hydroxyls of Glc1 are proximal to
the side chains E86 and K305, and the O2 hydroxyl is
involved in a water-mediated hydrogen bond to R339. The
reducing end O1 is coordinated with both the hydroxyl side
chain of S85, as well as with E51 via an ordered water
molecule. The binding cleft at the nonreducing end is more
open, which likely aids in accommodating the pseudotet-
rasaccharide acarbose. The O3 of the nonreducing end of
the acarviosine moiety is proximal to the side chains
of D91 and K90, whereas the O6 makes water-mediated
hydrogen bonds to the side chain of D384 and the pep-
tidic O of W383. However, these interactions apparently
do not contribute to the affinity for the sugar, as ITC ex-
periments demonstrate a nearly identical Kd for both
maltotriose and acarbose. The structures of many
ABC maltooligosaccharide-binding proteins have been
determined, revealing that ligand binding induces a
closure of the two domains over the sugar, mediated by
a flexible hinge region between the two domains. That
EUR_01830 cannot bind maltose suggests that all three
tryptophan-containing subsites must be occupied in
order to induce and stabilize closure of the two domains
around the sugar.
From these structures, it is clear that binding the
oligosaccharide GM, which contains an α1,6-linked
glucose at the nonreducing end of the sugar would nec-
essarily push the binding cleft open, as well as disrupt
the hydrogen-bonding between side chain of N191 and
the O6 of the nonreducing end of maltotriose (Fig. 5C).
However, it is difficult to envision how a much longer
oligosaccharide like maltoheptaose is accommodated
with high affinity. A loop created by residues 242–248
from the C-terminus closes the opening to the binding
cleft (Fig. 5E and F), with E246 extending upwards
toward the middle of the oligosaccharide curve, and both
S87 and D88 from the N-terminal domain projecting
downward to the middle of the oligosaccharide and in
front of the binding cleft. Presumably EUR_01830 would
have to open to accommodate a longer helical maltoo-
ligosaccharide, similar to the manner in which MalX is
somewhat propped open to accommodate the natural
helix created by the α1,4-linkages in maltoheptaose
(Abbott et al., 2010). In the MalX structure, a helix-loop-
helix created by residues 240–266 is positioned away
from the binding cleft allowing maltoheptaose access to
the binding site. In the EUR_01830 structure, an equiva-
lently positioned β-strand-loop-helix created by residues
Table 5. Data collection and refinement statistics of EUR_01830.
01830 – maltotriose 01830 – acarbose
PDB ID 4UA8 4UAC
Resolution range (Å)a 37.01–1.542 (1.597–1.542) 31.85–1.6 (1.657–1.6)
Space group P 21 21 2 P 21 21 2
Unit cell 99.691 110.495 38.515 90 90 90 99.805 110.408 38.473 90 90 90
Total reflectionsa 472 084 (30 736) 296 981 (14 671)
Unique reflectionsa 63 371 (6152) 55 134 (4 348)
Multiplicitya 7.4 (5.0) 5.4 (3.4)
Completeness (%)a 99.54 (98.12) 96.52 (77.70)
Mean I/sigma(I)a 30.19 (7.16) 23.56 (4.23)
Wilson B-factor 10.89 13.8
R-mergea 0.08121 (0.1752) 0.07917 (0.2257)
R-meas 0.08573 0.08776
CC1/2a 0.995 (0.974) 0.995 (0.926)
CC*a 0.999 (0.993) 0.999 (0.981)
R-worka 0.1370 (0.1476) 0.1443 (0.1571)
R-freea 0.1613 (0.1906) 0.1769 (0.1862)
Number of atoms 3 490 3 441
Macromolecules 2 916 2 899
Ligands 45 63
Water 529 479
Protein residues 383 383
RMS(Å) 0.012 0.01
RMS(°) 1.4 1.39
Ramachandran favored (%) 99 98
Ramachandran outliers (%) 0 0
Clashscore 0.69 1.56
Average B-factor 15.3 17.4
Macromolecules 13.4 15.8
Ligands 13.7 18.7
Solvent 25.7 26.8
a. Values in parenthesis are for the highest resolution shell.
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Fig. 5. Structure of the maltodextrin-binding protein EUR_01830.
A. Omit maps (σ = 3.0) displaying representative electron density for maltotriose and acarbose.
B. Overlay of the structures of EUR_01830 complexed with acarbose (gray ribbon) and with maltotriose (blue ribbon). Acarbose is displayed
as black sticks and maltotriose as blue sticks. The aromatic residues that cradle the maltodextrins are shown as sticks.
C. Close-up of the binding pocket of EUR_01830. Direct hydrogen-bonding interactions between the protein and maltrotriose/acarbose are
displayed as dashed lines. K91 and D384 have been omitted for clarity. Waters involved in water-mediated hydrogen-bonds are shown as
spheres.
D. Close-up end view of the hydrogen-bonding network that confers recognition of the reducing end sugar. Acarbose and the relevant amino
acids are shown as sticks, while waters involved in water-mediated hydrogen bonds are shown as red spheres. Dashed lines indicate
interactions within hydrogen bonding distance, and distances are displayed in Å. Here E246, though unlikely to contribute to
hydrogen-bonding, is shown for reference.
E. Close-up side view of EUR_01830 binding pocket demonstrating the manner in which E246, S87 and D88 may occlude the front of the
binding pocket. The loop of residues 242–248 is shown in black ribbon, and E246, S87 and D88 are shown in black sticks. Note that S87 was
observed in two conformations in the crystal structure.
F. Superposition of the coordinates of the acarbose-bound EUR_01830 (gray) and MalX of S. pneumoniae (blue, pdb 2XD3). The C-terminal
strand-loop-helix comprising residues 236–259 of EUR_01830 is displayed in black, and the corresponding helix-loop-helix comprising
residues 240–266 of MalX is displayed in dark blue. Acarbose is displayed as black sticks and maltoheptaose is displayed as blue sticks.
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236–259 would have to move similarly to accommodate
the longer oligosaccharide (Fig. 5F).
EUR_31480 and EUR_01240 provide binding for
smaller maltooligosaccharides and glucose
To understand how the additional ABC solute-binding pro-
teins observed in our starch-grown cells may contribute to
starch utilization, we expressed and purified EUR_01240,
EUR_31480 and EUR_21010 for determination of
their maltooligosaccharide-binding specificity (Table 4).
EUR_31480 can bind maltose (Kd = 563 ± 66 nM) and
maltotriose (Kd = 355 ± 0.4 nM) with similar affinity but
binds maltotetraose with slightly less affinity (Kd = 1670 ±
199 nM) and cannot bind longer maltoligosaccharides, or
any oligosaccharides containing an α1,6 linkage including
GM and GMM.Although the xylotriose-binding protein from
C. polysaccharolyticus displays the best sequence similar-
ity of structures in the PDB, we did not observe binding of
EUR_31480 to xylotriose.
EUR_01240 is a glucose and galactose-binding protein
and cannot bind maltose or lactose. The affinity of this
protein for galactose (Kd = 415 ± 20.2 nM) is nearly fivefold
better than for glucose (Kd = 1900 ± 460 nM) and overall
about 10-fold worse than the affinities reported for the
E. coli and S. typhimurium homologs (Zukin et al., 1977).
Despite trying different methods of measuring the protein
concentration for ITC experiments, our data consistently fit
a binding stoichiometry of n ∼ 0.5, which might suggest that
two molecules of protein bind one molecule of mono-
saccharide. Although this stoichiometry has not been
observed in any other solute-binding protein to the best of
our knowledge, some solute-binding proteins such as the
lactate-binding protein of the tripartite ATP-independent
periplasmic transporter in Thermus thermophilus HB8 can
dimerize (Akiyama et al., 2009). Due to the stoichiometry
observed and the fact that the EUR_01240 protein displays
an extra ∼ 100 amino acids at its C-terminus, we decided to
investigate the multimeric state of this protein. After incon-
sistent results were obtained with size exclusion chroma-
tography, we employed analytical ultracentrifugation to
determine whether EUR_01240, and for comparison both
EUR_31480 and EUR_01830, could dimerize in the pres-
ence or absence of substrate. Diffusion-corrected van
Holde–Weischet sedimentation coefficient distributions
indicated a clear shift to slightly larger values when maltoo-
ligosaccharides were added at saturating concentrations
(1 mM) to each of the proteins; however, these shifts
are consistent with maltooligosaccharide binding and
not protein–protein dimerization (Supporting Information
Fig. S2 and Table S4). The solution characteristics of
EUR_01240 at both high and low concentrations and in the
presence or absence of glucose suggest that it is a
monomer like other characterized ABC glucose/galactose-
binding proteins. Thus, we conclude that the unexpected
stoichiometry with EUR_01240 during ITC is simply due to
about 50% of the protein failing to bind in these experi-
ments, despite the fact that the protein remained soluble
and otherwise behaved normally.
We also purified and tested EUR_21010 for binding to
glucose and maltooligosaccharides but did not observe
binding. A predicted cellobiose phosphorylase encoding
gene upstream of EUR_21010 prompted us to test for
binding to cellooligosaccharides and revealed that
EUR_21010 has affinity for both cellobiose (Kd = 542 nM,
n = 0.846) and cellotetraose (Kd = 3009 nM, n = 1.009).
As mentioned earlier, this protein was observed at much
lower relative abundance compared with the other tested
ABC solute-binding proteins, and therefore we did not
think it was likely to contribute significantly to starch utili-
zation. This finding may suggest that E. rectale has the
ability to scavenge cellooligosaccharides generated by
the cellulose-degrading organisms that have recently
been identified in the human gut microbiota (Robert and
Bernalier-Donadille, 2003; Chassard et al., 2012).
Transcriptional analysis of select genes
In order to further explore the response of E. rectale to
growth on starch, we examined the transcriptional profile of
the genes encoding our five selected proteins during expo-
nential growth on glucose, APM and H7 (Table 6). The
transcripts for EUR_01830, EUR_01860 and EUR_21100
are upregulated during growth on starch compared with
glucose, although the observed fold increase is higher than
that in the proteomic data. Discrepancies in the fold
changes for transcriptomic and proteomic data from cells
cultured in the same conditions are well-reported for a
variety of organisms and are due to a variety of technical
and biological factors (Nie et al., 2007). Currently, little is
known about the posttranscriptional and posttranslational
regulatory processes of E. rectale, preventing a direct
comparison between fold changes observed on a tran-
scriptional vs proteomic level. Furthermore, limitations and
differences in how transcriptional vs proteomic data is
measured, as well as the turnover and stability of the
Table 6. Fold change in transcripts relative to growth in glucose.
Gene APM H7 P-valuea
EUR_21100 30.9 ± 3.8 37.1 ± 3.1 0.110
EUR_01860 11.04 ± 0.2 33.2 ± 4.9 0.011
EUR_01830 10.9 ± 2.6 113.3 ± 49.2 0.049
EUR_31480 −1.43 ± 0.5 3.6 ± 1.1 0.015
EUR_01240 −25.3 ± 2.8 −9.0 ± 4.1 0.022
a. Probability associated with a Student’s t-test comparing APM and
H7.
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transcripts and proteins will affect how well these two types
of information can be correlated (Haider and Pal, 2013).
More difficult to explain are the changes in the transcript
levels of EUR_31480 and EUR_01240 compared with the
proteomic data. The transcript for EUR_31480 appears to
be slightly upregulated during growth on H7 and slightly
repressed during growth on APM compared with glucose,
although the overall fold changes are quite modest. Sig-
nificantly less transcript for EUR_01240 was observed
during growth on starch compared with glucose, although
more of these proteins are detected in the starch-grown
cells. Note that cells were grown overnight in YCFA plus
glucose, then back-diluted 15-fold the following morning
into YCFA-containing glucose, APM or H7 for the tran-
scriptional and proteomic experiments. It is possible that
while new transcripts for EUR_01240 are not being made
during growth in starch, slow turnover of the synthesized
proteins and existing transcripts allow for relatively stable
levels of the proteins in both glucose- and starch-grown
cells. Excluding EUR_21100, more transcript is detected
in the H7 versus APM samples, as suggested by the
higher fold changes compared with glucose. H7 is a more
insoluble and resistant form of starch than APM, by virtue
of its higher amylose content, and the cell may be
responding to these subtle differences in starch structure.
Discussion
Previous reports have indicated that despite the fact that
E. rectale cannot degrade RS, it is typically associated with
starch granules in culture, and its abundance can increase
in the mammalian gut when the host consumes RS. In this
study, we identified two GH13 enzymes that participate in
starch degradation as well as three ABC glycan-binding
proteins involved in scavenging the liberated maltooligo-
saccharides and glucose, allowing us to propose a model
for how E. rectale targets starch in the intestinal tract
(Fig. 6). This model is similar to that for glycogen uptake in
S. pneumoniae (Abbott et al., 2010); in S. pneumoniae,
the cell wall anchored pullulanase SpuA degrades glyco-
gen into a ladder of malto-oligosaccharides, most of which
are specifically recognized by MalX for import into the cell.
In E. rectale, the maltotetraose-producing, cell-wall teth-
ered α-amylase EUR_21100 likely participates in the initial
anchoring of the bacterium to the starch polymer, a process
facilitated by the five predicted starch-binding CBMs found
at the N-terminus of the protein. The ability to attach to
starch particles in the intestinal tract is advantageous to
E. rectale and may serve to place it in close proximity to RS
degrading bacteria such as R. bromii. Prolonged hydroly-
sis of RS by R. bromii liberates many short maltooligosac-
Fig. 6. Model of starch digestion and maltooligosaccharide uptake by Eubacterium rectale. The multidomain EUR_21100 is tethered to the
peptidoglycan layer, and may anchor the bacterium to starch via its five N-terminal CBMs (predicted CBM family number as indicated,
U = unknown domain). Released oligosaccharides may be targeted by EUR_01830 and EUR_31480 for import into the cell. The location of
EUR_01860 is unknown. This maltogenic amylase produces some glucose, as suggested by its breakdown of maltotriose, and its presence on
the surface of the cell may generate glucose and maltose that can be captured by EUR_01240 and EUR_31480 respectively.
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charides and glucose (Ze et al., 2012), which could be
taken up by E. rectale via various solute-binding proteins
or a PTS. However, the degradation of starch granules is
generally initiated by attack of the surface, eventually
exposing internal amorphous regions that are more vulner-
able to hydrolysis (Foresti et al., 2014), and it is likely that
R. bromii performs this function as well, making the starch
accessible to E. rectale. This would allow E. rectale to grow
efficiently on RS in vivo, despite its relatively small reper-
toire of proteins that are upregulated in the presence of
starch.
Starch degradation by EUR_21100 results primarily in
maltotetraose and maltotriose, both of which are recog-
nized by the abundant cell surface proteins EUR_01830
and EUR_31480; previous studies have demonstrated
the ability of E. rectale to grow on maltotetraose (Ze et al.,
2012). EUR_01830 and EUR_31480 display both over-
lapping and distinct maltooligosaccharide-binding pro-
files. EUR_01830 is the most abundant upregulated
protein during growth on starch and targets longer maltoo-
ligosaccharides from maltotriose through maltoheptaose
with nearly equal affinity. Although it has weaker affinity for
GM, EUR_01830 may contribute to E. rectale’s ability to
grow on this branched oligosaccharide.
A key question that we aim to address in future studies
is the localization of EUR_01860. This glucosidase has
a predicted N-terminal transmembrane helix, though
whether it is exported to the outside of the cell and contrib-
utes to initial oligosaccharide processing or it is located
inside of the cell and responsible for breakdown of the
imported maltooligosaccharides is unknown. The sub-
strate profile of EUR_01860 suggests that this enzyme
targets maltooligosaccharides longer than maltotriose,
which could be imported via EUR_01830. However,
EUR_01860 produces maltose and maltotriose, which can
be harvested by EUR_31480 and EUR_01830 respec-
tively. Having EUR_01860 on the surface of the cell may be
most advantageous to E. rectale by allowing it to process
maltooligosaccharides generated by other bacteria,
including those with α1,6-linkages.
In addition to EUR_21100 and EUR_01860, E. rectale
has 11 other GH13 enzymes and one GH77 enzyme as
annotated in the CAZy database, all of which are predicted
to have a cytoplasmic location. Of these, several are
predicted to have glucosidase activity on α1,4 and/or α1,6
linked maltooligosaccharides and disaccharides to gener-
ate glucose. These glycoside hydrolases likely contribute
to the final processing of imported oligosaccharides as well
as to the breakdown of internal glycogen stores.
The relative abundance of the glucose-binding protein
EUR_01240 in all samples, as well as its relative fold
increase during growth on starch was somewhat surpris-
ing as neither EUR_21100 nor EUR_01860 generates
glucose as a major product, although many other starch-
utilizing gut bacteria including R. bromii and B. thetaio-
taomicron have surface enzymes that generate glucose
as a product of starch digestion (Koropatkin and Smith,
2010; Ze et al., 2012). Our quantitative PCR (qPCR) data
suggest that transcript levels for EUR_01240 are higher
during growth on glucose, although the protein is present
and modestly elevated during growth on starch. As little is
known about transcriptional and translational regulation in
E. rectale, we can only speculate that this protein may
experience less turnover during growth on starch. It is
possible that glucose is the most preferred carbon source
of E. rectale, and thus the omnipresence of EUR_01240
in the membrane ensures glucose capture. This idea is
supported by the lack of a dramatic increase in abun-
dance of predicted glucose transporters during cell growth
on glucose.
Between the three sequenced genomes of E. rectale
(strains DSM 17629, ATCC 33656 and M104/1), syntenic
loci for the putative operons encoding EUR_01830–
EUR_01860, EUR_31480–31540 and EUR_01240–
EUR_01260 are conserved, with ≥ 96% amino acid identity
between the individual protein homologs for EUR_01830,
EUR_01860, EUR_31480 and EUR_01240. The predicted
locus within the ATCC strain that is homologous to the
EUR_21100–21130 of our isolate, displays an insertion
after the EUR_21100 homolog (EUBREC_1081), and
includes a predicted DNAinvertase and transposase that is
not seen in the other two strains. While the homologous
protein to EUR_21100 in M104/1 (ERE_20420) is 99%
identical, the amino acid sequence for EUBREC_1081 is
more divergent, at 48% identical to EUR_21100, with most
of these differences taking place in the predicted CBM
region at the N-terminus of the protein. Overall, it seems
that the proteins involved in starch uptake in E. rectale
DSM 17629 are conserved among other isolates.
Transcriptional and proteomic data collected on the
related Clostridium cluster XIVa bacterium R. inulinovo-
rans during growth on inulin and starch has been
previously reported, demonstrating that polysaccharide
exposure induces enzyme and ABC transporter expres-
sion (Scott et al., 2011). During growth on starch, a solute-
binding protein and amylase from a similar operon
structure as EUR_01830–01860 were observed, as
well as another larger amylase of 1315 amino acids,
ROSEINA2194_03334, that is likely anchored to the cell
wall. Interestingly, this larger amylase, designated AmyB,
has a predicted domain structure with the catalytic
domain comprising residues ∼ 316–747, rather than at the
C-terminus of the protein as in EUR_21100. These types of
large, multidomain cell-wall anchored amylases can be
found in many of the Clostridium cluster XIVa organisms
and have a variety of domain organizations while seem-
ingly performing similar functions; the purified catalytic
domains of R. inulinovorans and Butyrvibrio fibrisolvens
Starch utilization by Eubacterium rectale 223
© 2014 John Wiley & Sons Ltd, Molecular Microbiology, 95, 209–230
both display amylase activity (Ramsay et al., 2006), similar
to EUR_21100. Thus, the starch degrading and oligosac-
charide import pathway described here for E. rectale may
describe a conserved pathway by which many human gut
Clostridium cluster XIVa organisms take advantage of the
abundant dietary carbohydrate starch.
Experimental procedures
Reagents
Primers used for cloning were synthesized by IDT DNA Tech-
nologies and are listed in Supporting Information Table S5.
Hylon VII (H7) was kindly provided by Ingredion (Bridgewater,
NJ, USA). All other chemicals were purchased from Sigma
Aldrich, with the exception of GM, GMM and pullulan that
were purchased from Megazyme.
Media and growth conditions
Eubacterium rectale DSM 17629 was routinely grown in
modified YCFA media (Yeast-casitone-fatty acid media, Ze
et al., 2012) supplemented with 0.2–0.5% glucose, H7 or
APM as the sole carbon source. Media was prepared aero-
bically, filter sterilized and equilibrated in a Coy anaerobic
chamber (85% N2, 10% H2, 5% CO2) for 1 h prior to dispens-
ing into sterile Hungate tubes for growth experiments.
Proteomic sample preparation
For proteomics, 1 mL of an overnight culture of E. rectale
grown in YCFA plus 2 mg mL−1 glucose was added to 14 mL
of YCFA media containing 2 mg mL−1 of glucose, APM or H7
as the sole carbon source in 15 mL screw-cap Hungate
tubes. Cultures were dispensed and sealed in the anaerobic
chamber then removed and grown at 37°C on a tube roller to
provide constant agitation. When the OD600 reached ∼ 0.6,
the cultures were harvested by centrifugation and quickly
frozen in liquid N2. Each culture was grown in triplicate. For
combined cell wall/cell membrane (CMW) samples, cells
were first thawed on ice in 8 mL of cold phosphate buffered
saline (PBS). Cells were lysed by three passages through a
French press at 2000 psi, then centrifuged at 10 000 × g for
15 min to remove unbroken cells. The supernatant was then
centrifuged at 10 000 × g for another 10 min, and the remain-
ing supernatant containing the cell wall and membrane was
subjected to ultracentrifugation at 200 000 × g for 2 h. The
pellet was then resuspended in 1 mL of high-salt buffer
(25 mM NaH2PO4, 5 mM EDTA, 1 M NaCl, pH 8.0) and incu-
bated on ice for 5 min, then centrifuged again at 200 000 × g
for 30 min. This high-salt buffer wash and spin was repeated
a second time, and the final pellet was resuspended in
0.15 mL of PBS then frozen in liquid N2 until all samples were
ready for proteomic analysis.
Quantitative mass spectroscopy
The CMW samples were submitted to MS Bioworks LLC
(http://ww.msbioworks.com, Ann Arbor, MI, USA) for Quant-
works Label-free Unfractionated proteomic analysis. Briefly,
samples were diluted 1:1 with 0.1% sodium dodecyl sulfate
(SDS), heated at 65°C for 10 min and quantified using Qubit
fluorimetry (Invitrogen). Samples were then mixed with
lithium dodecyl sulfate (LDS) buffer, and 10 μg of each
sample was loaded into separate lanes of a 10% SDS poly-
acrylamide gel electrophoresis (SDS-PAGE) gel and sepa-
rated ∼ 1 cm. The gel was stained with Coomassie, and the
entire mobility region of the gel was excised. Trypsin diges-
tion was performed using the ProGest Automated Protein
Digestion robot (Digilab). The excised gel was washed with
25 mM ammonium bicarbonate then acetonitrile, followed by
treatment with 10 mM dithiothreitol (DTT) at 60°C. The
samples were then alkylated with 50 mM iodoacetamide at
room temperature, then digested with trypsin (Promega) for
4 h at 37°C. The reaction was quenched with formic acid, and
the supernatants were analyzed by nano LC/MS/MS with a
Waters NanoAcquity HPLC system interfaced to a Ther-
mofisher Q Exactive. Peptides were loaded on a trapping
column and eluted over a 75 mm analytical column at
350 nL min−1 for a 1 h gradient. Both columns were packed
with Jupiter Proteo resin (Phenomenex). Mass spectropho-
tometry was performed in data-dependent mode with MS and
MS/MS performed in the Orbitrap at 70 000 FWHM (Full
width at half-maximum) and 17 500 FWHM resolution
respectively. The fifteen most abundant ions were selected
for MS/MS.
The resulting proteomic mass spectrum data were
searched using a local copy of Mascot against the Uniprot
E. rectale DSM 17629 proteome (combined forward and
reverse plus common contaminants such as keratin). A
peptide mass tolerance of 10 ppm, with a fragment mass
tolerance of 0.015 Da and a maximum of two missed cleav-
ages, was included. Mascot DAT files were parsed into the
Scaffold (version 3.5.1) software to create a nonredundant
list of proteins per sample. Data were filtered using a
minimum protein value of 90%, a minimum peptide value of
50% (Prophet scores) and requiring at least two unique pep-
tides per protein. Proteins were quantified by calculating the
NSAF of each protein as NSAF = (SpC/MW)/Σ(SpC/MW)N,
where SpC = Spectral Counts, MW = Protein MW in kDa and
N = Total Number of Proteins. NSAF was used to determine
the abundance of proteins within and across samples.
ANOVA on the three groups (GLU, H7 and APM) was also
performed, and P-values are included in Supporting Informa-
tion Table S1. The cellular localization of identified proteins
was predicted using PSORTb 3.0 (Yu et al., 2010).
Cloning and protein expression
The genes encoding EUR_01830 (residues 25–423),
EUR_01240 (residues 23–427), EUR_31480 (residues
27–462) and EUR_21010 (residues 26–464) were PCR
amplified from genomic DNA for ligation-independent cloning
into the pETite N-His vector (Lucigen Madison, WI, USA)
according to the manufacturer’s instructions. The N-terminal
primer contained a tobacco etch virus protease (TEV) cleav-
age site immediately downstream of the complementary
18 bp overlap (encoding the His tag) to create a
TEV-cleavable His-tagged protein. EUR_21100 (residues
45–1329) and EUR_01860 (residues 43–564) were PCR
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amplified from genomic DNA for ligation-independent cloning
into the pETite C-His vector (Lucigen Madison) according to
the manufacturer’s instructions. The resulting pETite plas-
mids were transformed into Rosetta(DE3) pLysS cells, plated
on LB agar containing 50 μg mL−1 kanamycin (Kan) and incu-
bated overnight at 37°C. For native protein expression,
these plates were used to inoculate 2 × 1 L of terrific broth
media supplemented with 50 μg mL−1 Kan and 30 ug mL−1
of chloramphenicol (Cm) for protein expression. Cells were
grown at 37°C to an OD600 of ∼ 0.6, Isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to a final concen-
tration of 0.5 mM, and the cells were grown at room
temperature (20–23°C) for an additional 16 h. Cells were
then harvested by centrifugation and flash-frozen in liquid N2.
Selenomethionine-substituted EUR_01830 was expressed
via the methionine inhibition method (Van Duyne et al., 1993).
Freshly transformed Rosetta(DE3) pLysS cells grown over-
night on LB/Kan agar plates were used to inoculate 100 mL
starter cultures of M9 minimal media containing 50 μg mL−1
Kan and 30 μg mL−1 Cm for growth overnight at 37°C. After
16 h, 50 mL of the starter culture was used to inoculate
2 × 1 L of M9 minimal media plus 50 μg mL−1 Kan, 30 μg mL−1
Cm and 5 μg mL−1 thiamine. Cultures were grown at 37°C to
an OD600 of ∼ 0.45, before adjusting the temperature to 23°C
for the remainder of the growth period. At this time, each 1 L
of media was supplemented with 100 mg each of L-lysine,
L-threonine, L-phenylalanine, and 50 mg each of L-leucine,
L-isoleucine, L-valine and L-selenomethionine. After 20 addi-
tional min of growth, the cells were induced with 0.5 mM
IPTG, and allowed to grow for 16 h. Cells were then har-
vested by centrifugation and flash-frozen in liquid N2.
Purification of native and selenomethionine-substituted
solute-binding proteins
His-tagged proteins were purified using a 5 mL Hi-Trap metal
affinity cartridge (GE Healthcare) according to the manufac-
turer’s instructions. The cell lysate was applied to the column
in His Buffer (25 mM NaH2PO4, 500 mM NaCl, 20 mM imida-
zole pH 7.4) and proteins were eluted with an imidazole (20–
300 mM) gradient. The His-tag was removed by incubation
with TEV protease (1:100 molar ratio relative to protein) at
room temperature for 2 h, then overnight at 4°C while dialyz-
ing against His Buffer. The cleaved protein was then
re-purified on the 5 mL Ni column to remove undigested
target protein, the cleaved His-tag and His-tagged TEV pro-
tease. Purified proteins were dialyzed against 20 mM
HEPES/100 mM NaCl (pH 7.0) prior to crystallization and
concentrated using Vivaspin 15 (10 000 MWCO) centrifugal
concentrators (Vivaproducts).
Protein crystallization and data collection
EUR_01830 was initially screened using a variety of commer-
cially available sparse matrix crystallization screens using a 96
well hanging drop format at both room temperature and 4°C.
Diffraction quality crystals of native EUR_01830 with maltotri-
ose complex were obtained by mixing the protein solution
(OD280 = 31 with 1 mM maltotriose) 1:1 with the well solution
containing 35–40% pentaerythritol propoxylate 5/4 PO/OH,
0.2 M NaCl and 0.1 M 2-(N-morpholino)ethanesulfonic acid
pH 5.0 in hanging drop experiment at 4°C. For data collection,
crystals were frozen by quickly transferring into cryoprotectant
made by mixing 80 μL of mother liquor with 20 μL of ethylene
glycol then plunging into liquid nitrogen. Native crystals of the
EUR_01830/acarbose complex were obtained by mixing the
protein solution (OD280 = 31 with 2 mM acarbose) 1:1 with a
well solution of 40% pentaerythritol propoxylate 5/4 PO/OH,
0.2 M NaCl and 0.1 M 2-(N-morpholino)ethanesulfonic
acid pH 6.0 in a hanging drop experiment at 4°C. These
crystals were also frozen by quickly swiping through cryopro-
tectant containing 80% crystallization solution plus 20%
ethylene glycol before flash-freezing in liquid nitrogen.
Selenmethionine-substituted protein crystals with acarbose
were grown and frozen in an identical manner as the native
protein plus acarbose. Single-wavelength anomalous diffrac-
tion (SAD) X-ray data for all seleno-methionine substituted
crystals with acarbose were collected at the Life Sciences
CollaborativeAccess Team (LS-CAT) ID-D beamline, whereas
the native X-ray data sets were collected at LS-CAT ID-F
beamline at the Advanced Photon Source at Argonne National
Labs, Argonne, IL, USA. All X-ray data were processed with
HKL3000 and scaled with SCALEPACK (Otwinowski and
Minor, 1997). The structure of EUR_01830 was determined
from the SAD data using the AutoSol subroutine within the
Phenix software package (Adams et al., 2002; Zwart et al.,
2008), including automatic model tracing. This initial model of
EUR_01830 was then utilized for molecular replacement in
Phaser (McCoy et al., 2007) against the native X-ray data
sets. Successive rounds of manual model building in Coot
(Emsley and Cowtan, 2004) and refinement in Phenix were
employed. Data collection and refinement statistics are pre-
sented in Table 5.
Isothermal titration calorimetry
ITC measurements for EUR_01830 with maltoheptaose, mal-
totriose, α-cyclodextrin and acarbose were performed on a
MicroCal VP-ITC. The protein was dialyzed against 20 mM
HEPES and 100 mM NaCl pH 7.0, and oligosaccharide solu-
tions were prepared using the dialysis buffer. Protein (215 μM)
was placed in the sample cell and the reference cell filled with
deionized water. After the temperature was equilibrated to
25°C, a first injection of 2 μL was performed followed by 29
subsequent injections of 10 μL each of substrate (3 mM)
α-cyclodextrin, maltoheptaose, maltotriose or acarbose. Calo-
rimetry was also attempted twice with maltose, but no binding
was observed. The solution was stirred at 305 rpm, and the
resulting heat of reaction was measured. Data were analyzed
using the Origin software package (MicroCal).
The remaining ITC measurements for EUR_01830 as well
as all of those for EUR_31480, EUR_01240 and EUR_21010
were performed on a low-volume (250 μL sample cell) TA
instruments NanoITC. A single trial repeat of the previously
obtained values for EUR_01830 on the VP-ITC verified that
the measurements did not vary instrument to instrument.
Proteins were dialyzed against 20 mM HEPES and 100 mM
NaCl pH 7.0, and oligosaccharide solutions were prepared
using the dialysis buffer. Protein (30–150 μM) was placed in
the sample cell and the reference cell filled with deionized
water. After the temperature was equilibrated to 25°C, a first
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injection of 0.75 μL was performed followed by 27 subsequent
injections of 1.75 μL of 0.5–5 mM of the substrates listed in
Table 5, plus cellobiose and cellotetraose (EUR_21010 only),
and the pullulan oligosaccharide GMM (EUR_01830 only).
The solution was stirred at 350 rpm, and the resulting heat of
reaction was measured. Data were analyzed using the Nano-
Analyze software package (TA instruments).
Enzymatic assays
Activity toward maltose and maltotriose was measured using
the GO kit from Sigma-Aldrich, according to the manufactur-
er’s instructions. Activity was measured at 37°C with the
enzyme concentration at 1 μg mL−1 and substrate concentra-
tion at 0.3%. The reactions were performed in 25 mM HEPES
pH 6.5, 150 mM NaCl, 0.02% Tween 80. Measurements were
performed for 30 min taking samples every 10 min. Reac-
tions were stopped at each time point through heating at
80°C for 10 min.
Activity toward polysaccharides was measured by deter-
mination of generated reducing ends through the bicin-
choninic acid (BCA) method (Waffenschmidt and Jaenicke,
1987), using glucose as a standard. EUR_01860 was used at
1 μg mL−1 in all assays, whereas EUR_21100 was used at
50 ng mL−1 for amylopectin, glycogen, amylose and starch
and 1 μg mL−1 for all other substrates. Amylopectin (potato),
amylose (potato) and pullulan were all initially made as con-
centrated solutions in dimethyl sulfoxide (DMSO) before dilu-
tion with water, resulting in a final DMSO concentration of 7%.
All other substrates were dissolved in water. All assays were
performed at 37°C in 25 mM HEPES pH 6.5, 150 mM NaCl,
0.02% Tween 80. Measurements were performed for 30 min
taking samples every 10 min. For soluble polysaccharides
reactions were stopped through the addition of the BCA
reagent. For starch samples, reactions were stopped through
the addition of NaOH to 50 mM. Samples were then sub-
jected to centrifugation at 20 000 × g for 5 min followed by
removal of the supernatant for reducing end measurement.
Thin layer chromatography
Assays for TLC analysis were performed at 37°C in 25 mM
HEPES pH 6.5, 150 mM NaCl, 0.02% Tween 80. The reac-
tions were allowed to proceed for 30 min, and samples were
taken every 10 min and stopped by the addition of NaOH to
50 mM. These reactions were spotted onto TLC Silica gel 60
F254 20 × 20 cm glass plates (Millipore) and separated with
the solvent acetonitrile : ethyl acetate : isopropanol : water
(85:20:50:50) until the solvent front was within 1 cm of the top
of the plate. The sugars were then stained with 0.3% (w/v)
N-(1-napthyl)ethylenediamine, 5% (v/v) sulfuric acid in metha-
nol and heated until spots developed.
Analytical ultracentrifugation (sedimentation
velocity measurements)
The maltooligosaccharide binding proteins EUR_01240,
EUR_01830 and EUR_31480 were measured in the presence
and absence of saturating (1 mM) glucose, maltotriose and
maltose respectively. Experiments were performed in a
Beckman Optima XL-I analytical ultracentrifuge at the Center
for Analytical Ultracentrifugation of Macromolecular Assem-
blies at the University of Texas Health Science Center at San
Antonio. All samples were measured at 35 000 rpm and
scanned at 280 nm. Data were acquired in intensity mode. All
samples were measured in a buffer containing 20 mM HEPES
pH 7 and 100 mM NaCl. Experimental data were collected at
20°C using 1.2 cm epon 2-channel centerpieces (Beckman-
Coulter), using an An60Ti rotor. All conditions were measured
at two loading concentrations, OD280 = 0.3 and OD280 = 0.9
(see Supporting Information Table S4). Hydrodynamic correc-
tions for buffer density and viscosity were estimated by
UltraScan to be 1.00293 g mL−1 and 1.01295 cP. The partial
specific volume was estimated by UltraScan from protein
sequence analogous to methods outlined previously (Laue
et al., 1992) and found to be 0.7225 mL g−1 for EUR_01830,
0.716 mL g−1 for EUR_01240 and 0.7191 mL g−1 for
EUR_31480. All data were analyzed with UltraScan-III ver.
3.1, release 1796 (Demeler et al., 2014), according to method
described in (Demeler, 2010). Optimization was performed by
2-dimensional spectrum analysis (2DSA) (Brookes et al.,
2010) with simultaneous removal of time- and radially invari-
ant noise contributions (Schuck and Demeler, 1999).
Diffusion-corrected integral sedimentation coefficient distribu-
tions were obtained from the enhanced van Holde–Weischet
analysis (Demeler and van Holde, 2004). All calculations were
performed on the Lonestar cluster at the Texas Advanced
Computing Center at the University of Texas at Austin.
qPCR
For qPCR of the genes encoding EUR_21100, EUR_01860,
EUR_01830, EUR_31480 and EUR_01240, cells were grown
as described above for the proteomic study, except cells
(OD600 = 0.6) were arrested by adding 3 mL of culture into
6 mL of RNA protect, incubating for 5 min, centrifuged at
5500 × g for 5 min and the cell pellet was stored at −80°C until
RNA extraction. Total RNA was isolated using the RNeasy
Minikit (Qiagen) according to the manufacturer’s instructions
with the exception that the lysis buffer was supplemented with
1% lysozyme and resuspended cells were lysed by bead-
beating with acid-washed glass beads (Sigma Aldrich) using a
vortex at intervals of 20 s on and 20 s off for 10 min. DNA
digestion was performed with TURBO™ DNase I (Ambion) via
two digests of 20 min each. Following DNA digestion, control
PCR experiments were performed to ensure that there was no
DNA contamination in the RNA preparations. RNA Reverse
transcription was performed with 2 μg of RNA, 1 pmol random
primers (Invitrogen) and SuperScript III reverse transcriptase
(Invitrogen) according to the manufacturer’s instructions.
Synthesized cDNA was purified using a Gel-Extraction Kit
(Qiagen) according to the manufacturer’s instructions. cDNA
quantification was performed with a Mastercycler® ep realplex
(Eppendorf), using KAPASYBR® FAST qPCR Master Mix and
500 nM primers for 40 cycles of 95°C for 3 s, 55°C for 8 s, 72°C
for 20 s, followed by a melting step to determine amplicon
purity. Primers used for qPCR are listed in Supporting
Information Table S5. The cDNA quantification was normal-
ized across samples via amplification of gapA encoding
glyceraldehyde-3-phosphate dehydrogenase, a glycolytic
enzyme. The GapA protein was observed at the same abun-
dance in all proteomic samples.
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